Experiments demonstrating that fluvastatin inhibits NK cell-mediated lysis of tumor cells elicited both upon LFA1-ICAM1 interaction and upon triggering through specific activating receptors are described in File S1 and depicted in Figure S1, S2, S3. Here, ICAM1 is linked to neoplasm.